Oak Street Health (OSH) Stock Forecast, Price & News

13 Wall Street equities research analysts have issued "buy," "hold," and "sell" ratings for Oak Street Health in the last year. There are currently 12 hold ratings and 1 buy rating for the stock. The consensus among Wall Street equities research analysts is that investors should "hold" OSH shares. A hold rating indicates that analysts believe investors should maintain any existing positions they have in OSH, but not buy additional shares or sell existing shares.
View OSH analyst ratings or view top-rated stocks.

13 analysts have issued 1 year target prices for Oak Street Health's shares. Their OSH share price forecasts range from $21.00 to $39.00. On average, they predict the company's stock price to reach $35.22 in the next year. This suggests that the stock has a possible downside of 9.7%.
View analysts price targets for OSH or view top-rated stocks among Wall Street analysts.

Oak Street Health, Inc. (NYSE:OSH) announced its quarterly earnings data on Tuesday, February, 28th. The company reported ($0.56) EPS for the quarter, topping analysts' consensus estimates of ($0.58) by $0.02. The company had revenue of $577.70 million for the quarter, compared to the consensus estimate of $571.26 million. The firm's quarterly revenue was up 46.6% on a year-over-year basis. During the same quarter in the previous year, the company posted ($0.62) earnings per share.

17 employees have rated Oak Street Health Chief Executive Officer Peter Botten on Glassdoor.com. Peter Botten has an approval rating of 71% among the company's employees.

Based on aggregate information from My MarketBeat watchlists, some companies that other Oak Street Health investors own include Alibaba Group (BABA), Tesla (TSLA), Adobe (ADBE), NVIDIA (NVDA), Okta (OKTA), Zoom Video Communications (ZM), Autodesk (ADSK), Boeing (BA), Lockheed Martin (LMT) and Micron Technology (MU).

(OSH) raised $250 million in an IPO on Thursday, August 6th 2020. The company issued 15,600,000 shares at $15.00-$17.00 per share. J.P. Morgan, Goldman Sachs and Morgan Stanley acted as the underwriters for the IPO and William Blair, Piper Sandler, Baird and SunTrust Robinson Humphrey were co-managers.

Oak Street Health trades on the New York Stock Exchange (NYSE) under the ticker symbol "OSH."

Oak Street Health's stock is owned by a number of retail and institutional investors. Top institutional investors include HAP Trading LLC (0.00%), JPMorgan Chase & Co. (0.00%), Belvedere Trading LLC (0.00%), Wolverine Asset Management LLC (0.00%), Simplex Trading LLC (0.00%) and Barclays PLC (0.00%). Insiders that own company stock include Brian Clem, General Atlantic Llc, Geoffrey M Price, Geoffrey M Price, Griffin Myers, Michael Robert Martin, Michael T Pykosz, Michael T Pykosz, Newlight Partners Lp, Robert Guenthner, Shawn Henry and Timothy M Cook.
View institutional ownership trends.

One share of OSH stock can currently be purchased for approximately $39.00.

Oak Street Health (NYSE:OSH) has a market capitalization of $9.52 billion and generates $2.16 billion in revenue each year. The company earns $-509,200,000.00 in net income (profit) each year or ($2.21) on an earnings per share basis.

The company employs 6,000 workers across the globe.

Oak Street Health's mailing address is 30 W. MONROE ST. STE. 1200, CHICAGO IL, 60603. The official website for the company is www.oakstreethealth.com. The company can be reached via phone at 844-871-5650 or via email at investors@oakstreethealth.com.